Korean J Clin Microbiol.  2007 Oct;10(2):84-89.

Frequency of Mutation of Codon 249, Overexpression of p53, and Hepatitis B Virus DNA Positivity in Hepatocellular Carcinoma

Affiliations
  • 1Department of Laboratory Medicine, Chosun University Medical School, Gwangju, Korea. sjbjang@chosun.ac.kr
  • 2Department of Pathology, Chosun University Medical School, Gwangju, Korea.
  • 3Department of General Surgery, Chosun University Medical School, Gwangju, Korea.
  • 4Department of Internal Medicine, Chosun University Medical School, Gwangju, Korea.
  • 5Research Center for Resistant Cells, Chosun University Medical School, Gwangju, Korea.

Abstract

BACKGROUND: In hepatocellular carcinoma (HCC), the frequency of p53 mutation and the association with hepatitis B virus (HBV) infection varies with geographic locations and risk factors. The aim of this study was to determine the frequency of codon 249 mutation of p53, p53 overexpression, and HBV DNA positivity and to observe the relationship between them in Korean HCC.
METHODS
We analyzed overexpression of p53 in hepatoma tissue from 17 HCC patients by immunohistochemistry (IHC), specific mutations at the third base position of codon 249 by PCR-restriction fragment length polymorphism (PCR-RFLP) method, and presence of HBV by nested PCR.
RESULTS
Although a point mutation at codon 250 was seen in one (5.8%) of 17 patients, no codon 249 mutations were found in the patient cohort. The p53 protein was overexpressed in 4 (23.5%) of 17 HCCs. PCR for HBV DNA from HCCs showed a positivity rate of 82.4% (14 of 17 specimens).
CONCLUSION
In HCC of this study, HBV infection was not associated with either 249 mutation or overexpression of p53, and overexpression of p53 protein seemed to be related to other than this mutation.

Keyword

Hepatocellular carcinoma; Hepatitis B virus; p53 mutation; p53 overexpression; Immunohistochemistry

MeSH Terms

Carcinoma, Hepatocellular*
Codon*
Cohort Studies
DNA
Geographic Locations
Hepatitis B virus*
Hepatitis B*
Hepatitis*
Humans
Immunohistochemistry
Point Mutation
Polymerase Chain Reaction
Risk Factors
Codon
DNA
Full Text Links
  • KJCM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr